| FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection LM Johansen, JM Brannan, SE Delos, CJ Shoemaker, A Stossel, C Lear, ... Science translational medicine 5 (190), 190ra79-190ra79, 2013 | 379 | 2013 |
| A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity LM Johansen, LE DeWald, CJ Shoemaker, BG Hoffstrom, ... Science translational medicine 7 (290), 290ra89-290ra89, 2015 | 257 | 2015 |
| Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection CJ Shoemaker, KL Schornberg, SE Delos, C Scully, H Pajouhesh, ... PloS one 8 (2), e56265, 2013 | 169 | 2013 |
| Arbidol and other low-molecular-weight drugs that inhibit Lassa and Ebola viruses CE Hulseberg, L Fénéant, KM Szymańska-de Wijs, NP Kessler, ... Journal of virology 93 (8), 10.1128/jvi. 02185-18, 2019 | 140 | 2019 |
| Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1+ Endolysosomes Is a Rate … RM Mingo, JA Simmons, CJ Shoemaker, EA Nelson, KL Schornberg, ... Journal of virology 89 (5), 2931-2943, 2015 | 139 | 2015 |
| α5β1-Integrin controls ebolavirus entry by regulating endosomal cathepsins KL Schornberg, CJ Shoemaker, D Dube, MY Abshire, SE Delos, ... Proceedings of the National Academy of Sciences 106 (19), 8003-8008, 2009 | 112 | 2009 |
| A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models AR Garrison, CJ Shoemaker, JW Golden, CJ Fitzpatrick, JJ Suschak, ... PLoS neglected tropical diseases 11 (9), e0005908, 2017 | 87 | 2017 |
| GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection JW Golden, CJ Shoemaker, ME Lindquist, X Zeng, SP Daye, JA Williams, ... Science Advances 5 (7), eaaw9535, 2019 | 70 | 2019 |
| Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography EEH Tran, JA Simmons, A Bartesaghi, CJ Shoemaker, E Nelson, ... Journal of virology 88 (18), 10958-10962, 2014 | 66 | 2014 |
| Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure SC Johnston, KM Ricks, A Jay, JL Raymond, F Rossi, X Zeng, J Scruggs, ... PloS one 16 (2), e0246366, 2021 | 65 | 2021 |
| Exploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type I interferon blockade in mice ME Lindquist, X Zeng, LA Altamura, SP Daye, KL Delp, C Blancett, ... Journal of Virology 92 (21), 10.1128/jvi. 01083-18, 2018 | 52 | 2018 |
| Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry D Dube, KL Schornberg, CJ Shoemaker, SE Delos, TS Stantchev, ... Proceedings of the National Academy of Sciences 107 (38), 16637-16642, 2010 | 52 | 2010 |
| Mapping of ebolavirus neutralization by monoclonal antibodies in the ZMapp cocktail using cryo-electron tomography and studies of cellular entry EEH Tran, EA Nelson, P Bonagiri, JA Simmons, CJ Shoemaker, ... Journal of virology 90 (17), 7618-7627, 2016 | 36 | 2016 |
| Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis DR Smith, CJ Shoemaker, X Zeng, AR Garrison, JW Golden, ... PLoS Pathogens 15 (9), e1008050, 2019 | 35 | 2019 |
| FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med 5: 190ra79 LM Johansen, JM Brannan, SE Delos, CJ Shoemaker, A Stossel, C Lear, ... | 30 | 2013 |
| A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice JJ Suschak, JW Golden, CJ Fitzpatrick, CJ Shoemaker, CV Badger, ... npj Vaccines 6 (1), 31, 2021 | 29 | 2021 |
| A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci Transl Med 7: 290ra89 LM Johansen, LE DeWald, CJ Shoemaker, BG Hoffstrom, ... | 29 | 2015 |
| Nanoplasmid vectors co-expressing innate immune agonists enhance DNA vaccines for venezuelan equine encephalitis virus and ebola virus JJ Suschak, LC Dupuy, CJ Shoemaker, C Six, SA Kwilas, KW Spik, ... Molecular Therapy Methods & Clinical Development 17, 810-821, 2020 | 28 | 2020 |
| The genetic adjuvants interleukin-12 and granulocyte-macrophage colony stimulating factor enhance the immunogenicity of an Ebola virus deoxyribonucleic acid vaccine in mice JJ Suschak, K Bagley, CJ Shoemaker, C Six, S Kwilas, LC Dupuy, ... The Journal of Infectious Diseases 218 (suppl_5), S519-S527, 2018 | 19 | 2018 |
| The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice JW Golden, X Zeng, CR Cline, JM Smith, SP Daye, BD Carey, ... PLoS Pathogens 18 (5), e1010485, 2022 | 15 | 2022 |
